Based on the aforementioned, it seems that an mRNA construct encoding CA125 protein, which is upregulated and overexpressed in HGSC tumor cells, delivered by tumor targeted nanoparticles might represent an effective alternative approach for treating of ovarian cancer. Here, MUC16 is linked to neoplasm.